- Condition: Bacterial Conjunctivitis
Interventions: Drug: Moxifloxacin Ophthalmic Solution, 0.5%; Drug: Ofloxacin Ophthalmic Solution, 0.3%
Sponsors: Alcon Research; Alcon Research
Recruiting - verified May 2012 - Conditions: Pharmacokinetics of Isavuconazole; Healthy Volunteers
Interventions: Drug: Isavuconazole; Drug: Placebo; Drug: Moxifloxacin
Sponsors: Astellas Pharma Inc; Astellas Pharma Global Development, Inc.; Basilea Pharmaceutica International Ltd
Recruiting - verified April 2012 - Condition: Healthy Volunteers
Interventions: Drug: LY2484595; Drug: Placebo; Drug: Moxifloxacin
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified March 2012 - Condition: Healthy Volunteers
Interventions: Drug: LY3009104; Drug: Placebo; Drug: moxifloxacin
Sponsors: Eli Lilly and Company; Eli Lilly and Company; Incyte Corporation
Recruiting - verified March 2012 - Condition: Pediculosis
Interventions: Drug: Ha44; Drug: Ha44 Placebo; Drug: Moxifloxacin Placebo; Drug: Moxifloxacin
Sponsors: Hatchtech Pty Ltd; Hatchtech Pty Ltd
Not yet recruiting - verified January 2012 - Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Dexpramipexole; Drug: Dexpramipexole; Drug: Dexpramipexole Placebo; Drug: Moxifloxacin
Sponsors: Biogen Idec; Biogen Idec
Recruiting - verified January 2012 - Conditions: Insulin Sensitivity; Cardiovascular Risk; Perimenopausal Disorder
Intervention: Drug: Ortho Cyclen®
Sponsors: Virginia Commonwealth University; Virginia Commonwealth University; American Heart Association
Recruiting - verified November 2011 - Condition: Cataracts
Interventions: Drug: Moxifloxacin; Drug: besifloxacin
Sponsors: Bucci Laser Vision Institute; Bucci Laser Vision Institute
Recruiting - verified July 2011 - Condition: Cataracts
Intervention:
Sponsors: Bucci Laser Vision Institute; Bucci Laser Vision Institute
Recruiting - verified July 2011 - Conditions: Keratoconus; Ectasia; Degeneration
Interventions: Drug: Ciprofloxicine or Vigamox or other.; Drug: Nonsteroidal (Acular, Acuvail, Voltaren Xibrom, etc); Drug: Steroid (FML, Pred Forte, Flarex, etc.)
Sponsors: Innovative Medical; Innovative Medical
Recruiting - verified April 2012 - Conditions: Keratoconus; Ectasia; Degeneration
Intervention:
Sponsors: Innovative Medical; Innovative Medical
Recruiting - verified February 2012 - Condition: Intra-Abdominal Infection
Interventions: Drug: Moxifloxacin (Avelox, BAY12-8039); Drug: Ertapenem, Amoxicillin/clavulanate
Sponsors: Bayer; Bayer
Recruiting - verified May 2012 - Condition: Infections
Intervention: Drug: Moxifloxacin (Avelox, BAY12-8039)
Sponsors: Bayer; Bayer
Recruiting - verified May 2012 - Conditions: Keratoconus; Ectasia; Degeneration
Interventions: Drug: Ciprofloxicine or Vigamox or other.; Drug: Nonsteroidal (Acular, Voltaren Xibrom, etc); Drug: Steroid (FML, Pred Forte, Flarex, etc.)
Sponsors: Innovative Medical; Innovative Medical
Recruiting - verified February 2012 - Condition: Contraception
Interventions: Drug: ortho tricyclen; Drug: Trinessa
Sponsors: William Beaumont Hospitals; William Beaumont Hospitals
Recruiting - verified August 2011 - Condition: Conjunctivitis
Interventions: Drug: moxifloxacin; Drug: polytrim
Sponsors: University of Rochester; University of Rochester
Recruiting - verified August 2011
 |
Avelox Clinical Trials |
